UBX News
Archived Headlines
- US IPO Week Ahead: Cybersecurity firm Carbon Black leads in 8 IPO week 04/27/18
- Unity Biotechnology, an osteoarthritis biotech, sets terms for $85 million IPO 04/23/18
- US IPO Weekly Recap: Spotify dances to its own tune with a $32 billion listing 04/06/18
- Unity Biotechnology files for an $85 million IPO 04/05/18
Pushing preclinical: Wave of early-stage biotech IPOs tests investor risk appetite
Biotechs are among the most risky of IPOs due to the binary nature of the success… or failure of their drugs. In the past, most biotechs delayed public offerings until they at least showed clinical evidence of their safety or efficacy. But in 2018,...read more
US IPO Weekly Recap: Carbon Black continues hot tech streak in 8 IPO week
Growth is good. IPO investors are still sweet on the tech sector, with cybersecurity provider Carbon Black (CBLK) up 26% on its debut. The other high-growth offering, ...read more
Unity Biotechnology prices $85 million IPO at $17 midpoint
Unity Biotechnology, a preclinical biotech developing therapies to reduce the effects of aging, raised $85 million by offering 5 million shares at $17, the midpoint of the $16 to $18 range. Unity Biotechnology plans to list on the Nasdaq under the symbol UBX....read more
Can Unity Biotechnology find a cure for age?
One of the largest biotechs of the 2018 IPO market is going public this week. Unity Biotechnology (UBX) plans to raise $85 million at a market cap of $787 million. Its goal? To grasp the holy grail of medicine: a therapy that combats the...read more